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Myelination occurs selectively around neuronal axons to increase the efficiency and velocity of 
action potentials. While oligodendrocytes are capable of myelinating permissive structures in the 
absence of molecular cues, structurally permissive neuronal somata and dendrites remain 
unmyelinated. Utilizing a purified spinal cord neuron-oligodendrocyte myelinating coculture 
system, we demonstrate that disruption of dynamic neuron-oligodendrocyte signaling by 
chemical crosslinking results in aberrant myelination of the somatodendritic compartment of 
neurons. We hypothesize that an inhibitory somatodendritic cue is necessary to prevent non-
axonal myelination. Using next-generation sequencing and candidate profiling, we identify 
neuronal Junction Adhesion Molecule 2 (JAM2) as an inhibitory myelin-guidance molecule. Taken 
together, our results demonstrate that the somatodendritic compartment directly inhibits 
myelination, and suggest a model in which broadly indiscriminate myelination is tailored by 
inhibitory signaling to meet local myelination requirements. 
 
The central nervous system (CNS) greatly benefits from oligodendrocyte myelination. Myelin supports the 
clustering of ion channels to nodes of Ranvier and increases the resistance across the axonal membrane. 
These properties generate the saltatory conduction of action potentials, ensuring rapid and efficient 
neural communication over longer distances in a more compact space (Zalc et al., 2008). It has long been 
appreciated that myelin, with very few exceptions, forms selectively around axons (Braak et al., 1977; 
Lubetzki et al., 1993; Blinzinger et al., 1972; Remahl and Hildebrand, 1985; Cooper and Beal, 1977). This 
begs the fundamental question: how does an oligodendrocyte, the myelin-forming cells of the CNS, target 
each of its many myelin segments exclusively to axons?  
Very little is currently known about axon selection by oligodendrocytes. More well understood are the 
consequences of when myelin fails to form correctly around axons, such as in leukodystrophies, or when 
myelin is attacked by the immune system, as in multiple sclerosis. In such cases, neuronal function is 
impaired and neurons eventually degenerate if myelin is not reformed (Fancy et al., 2011; Franklin and 
ffrench-Constant, 2008; Trapp and Nave, 2008; Yuen et al., 2014). In development, the coordinated 
differentiation and myelination of thousands of spatially distributed oligodendroglia is thought to be 
extrinsically determined, perhaps by neuronal activity. Indeed, recent findings suggest that neuronal 
activity is involved in modulating axon selection and the extent of myelin segment formation (Gibson, 
2014; Hines et al., 2015; Mensch et al., 2015). 
An unexplored aspect of myelination is the avoidance of selecting non-axonal targets. In CNS gray 
matter, oligodendrocytes must select axons while avoiding neuronal cell bodies, dendrites and processes 
of other glial cells. How is this specificity accomplished? Little evidence of non-axonal oligodendrocyte 
myelination exists (Blinzinger et al., 1972; Braak et al., 1977). Curiously, in vitro, oligodendrocyte 
myelination is not limited to axons: oligodendrocytes produce myelin membranes on planar glass 
coverslips, cylindrical polystyrene nanofibers (Bechler et al., 2015; Lee et al., 2012), and conical glass 
micropillars (Mei et al., 2014). These observations suggest that myelin substrate selection is not cell-
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intrinsically limited to physiologically relevant axon-like geometries, and that an inductive cue is not strictly 
required for differentiation and myelination. Oligodendrocyte cell processes are thus likely sensitive to 
cell-extrinsic ‘myelin guidance’ cues that ensure only correct selection of pre-myelinated axons. 
We propose three potential mechanisms that would ensure correct axonal selection (Fig 1a). An 
attractive signal may be expressed by the neuronal axon (Fig 1a, ‘Attraction’) to specifically promote 
myelin formation. Alternatively, proper myelination of axons may be achieved by expression of an 
inhibitory cue by the neuron’s somatodendritic compartment (Fig 1a, ‘Inhibition’). Here, oligodendrocyte 
processes form myelin segments around permissive axons but not on inhibitor-expressing structures. 
However, the Attraction and Inhibition models are not mutually exclusive, and both modes of signaling 
may be at play to ensure proper targeting of myelin segments (Fig 1a, ‘Mixed’). Which of these signaling 
mechanisms are active during developmental myelination? By utilizing a purified spinal cord neuron-
oligodendrocyte myelinating coculture system, we demonstrate that disruption of dynamic neuron-
oligodendrocyte signaling results in aberrant myelination of the somatodendritic compartment of neurons 
indicative of an active inhibitory mechanism. Using next-generation sequencing and candidate profiling, 
we identify Junction Adhesion Molecule 2 (JAM2) as a somatodendritic protein necessary and sufficient to 
inhibit oligodendrocyte myelination. Taken together, our results demonstrate that the somatodendritic 
compartment directly inhibits myelination, and provide a model in which broadly indiscriminate 
myelination is tailored by inhibitory signaling to meet local myelination requirements. 
 
Results 
The somatodendritic compartment is biophysically permissive to myelin ensheathment 
To understand the nature of selectivity and fidelity of the myelination process, we reasoned that the 
presence of a somatodendritic inhibitor would only be required if oligodendrocytes are capable of 
ensheathing the spherical shape of a neuron cell body (Fig 1b). To test this possibility, we cultured 
primary rat oligodendrocyte precursor cells (OPCs) on nanofibers with 20-micrometer diameter 
polystyrene beads that mimic neuron cell body geometry (Fig 1c). We find that differentiated myelin basic 
protein-positive (MBP+) oligodendrocytes readily ensheathe myelin membranes around both nanofibers 
and beads (Fig 1d).  
We then asked whether the somatodendritic compartment remains unmyelinated due to lack of 
attraction, or expression of inhibition? To investigate this question, we developed a primary purified spinal 
cord neuron (SCN) and oligodendroglial myelinating coculture system (Fig 1b,e-i). The SCN cultures 
robustly exhibited extensive axons, dendrites, and formed neuronal synapses over the course of three 
weeks in vitro (Fig 1e-g). Under normal conditions, purified OPCs seeded onto mature SCN cultures 
proliferate, differentiate after approximately one week in vitro (Fig 1h-i), and form compact layers of 
myelin membrane around axons (Fig 1j). Oligodendrocytes wrap myelin membrane around axons while 
avoiding neuron somata and dendrites (Fig 2a) (Lubetzki et al., 1993), recapitulating gray matter 
myelination patterns in vitro. We then asked whether dynamic neuron-oligodendrocyte signaling is 
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required to prevent myelination of the somatodendritic compartment. Prior to seeding neuron cultures with 
OPCs, we treated the neurons with the chemical cross-linker paraformaldehyde (PFA) (Rosenberg et al., 
2008). Surprisingly, oligodendrocytes wrapped myelin membranes on fixed neuron somata and dendrites 
in addition to axons (Fig 2b-c), and form multiple compacted layers of myelin membrane around cellular 
processes (Fig 2d-e). It is important to note, that paraformaldehyde cross-linking and the extended period 
of coculturing, subcellular structures are not well maintained (Rosenberg et al., 2008), making it 
impossible to determine whether myelinated structures are axons or dendrites. Based on our 
observations that (1) cultured oligodendroglia ensheathe bare nanofibers and microbeads, (2) avoid 
ensheathing neural somatodendritic compartments in vitro and in vivo, yet (3) aberrantly ensheathe 
cross-linked somata and dendrites, we hypothesize that neurons must express inhibitory molecules to 
prevent somatodendritic myelination. 
 
Differential RNA-seq and candidate profiling for myelination-inhibitory molecules  
To identify candidate inhibitory molecules, we conducted next-generation RNA-sequencing of SCN as 
well as dorsal root ganglion neuron (DRG) cultures (Fig 3a). We reasoned that differential expression 
analysis would increase the likelihood of identifying a somatodendritic inhibitor of myelination because 
SCN cultures develop extensive dendritic arbors around their somata, while pseudo-unipolar DRG 
neurons lack true dendrites. Candidate inhibitory proteins were chosen based on the following criteria: 
proteins that have (1) significantly higher expression in SCNs as compared to DRGs, and (2) 
transmembrane domains (Fig 3b). The differential RNA-seq analysis yielded two distinct populations of 
transcripts, representing higher expression in either DRGs (Fig 3b-d, black) or SCNs (Fig 3b-d, dark 
gray/pink). Several genes that have been described in the literature as expressed in either DRGs or 
SCNs were also differentially expressed in our analysis (Fig 3d, black and gray bars). Overall, 170 unique 
genes were identified as candidate inhibitory proteins (Fig 3b-d, pink). By profiling and prioritizing 
candidates from the RNAseq analysis, we identified the protein Junction Adhesion Molecule 2 (JAM2) as 
a differentially expressed (Fig 3d-e) potential inhibitor of myelination because of its low expression in 
DRG somata (Fig 3f, insert), little to no expression in the majority of DRG (Fig 3f) and SCN axons (Fig 3g), 
and its high expression and specific localization on the somatodendritic compartment of SCN (Fig 3g). 
 
JAM2 is sufficient to inhibit oligodendroglial wrapping  
JAM2 is a single-pass transmembrane protein with two extracellular immunoglobulin-like domains 
(Arcangeli et al., 2013). We found that the extracellular portion of JAM2 fused to the Fc region of 
immunoglobulins (‘JAM2-Fc’) strongly binds to MBP-positive oligodendrocytes and weakly to PDGF 
receptor alpha-positive (PDGFRα+) OPCs (Fig 4a) compared to an Fc only negative control (Fig 4b). This 
suggests that oligodendroglia express at least one JAM2 receptor, and the expression of JAM2 
receptor(s) is upregulated as oligodendroglia differentiate. We hypothesized that if JAM2 acts to inhibit 
myelination, oligodendrocytes will avoid wrapping JAM2-coated permissive structures in vitro. To test this 
 5 
possibility, we adapted the micropillar array platform (Mei et al., 2014) (Fig 4c) to assay the activity of Fc-
fusion proteins on oligodendroglial wrapping. Wildtype OPCs were seeded onto micropillars coated with 
either JAM2-Fc or Fc alone. Under control conditions, OPCs and oligodendrocytes associate with 
micropillars and wrap them with PDGFRα+ or MBP+ membranes. When a single optical section is taken 
through the micropillar array, immunostained OPC and oligodendrocyte wrapping is visualized as a ring 
(Figure 4d). Compared to Fc alone, oligodendrocytes wrap significantly fewer JAM2-Fc coated 
micropillars (Fig 4e-h, 85.7% reduction). Interestingly, even OPC wrapping of micropillars is significantly 
reduced in the JAM2-Fc condition compared with Fc alone (Fig 4h; 66.6% reduction). We reasoned that 
we might observe a decrease in OPC and oligodendrocyte wrapping if oligodendroglia failed to adhere or 
differentiate on JAM2-Fc coated surfaces. Due to technical limitations of imaging cells within the 
micropillar fields, we quantified the densities of OPCs and oligodendrocytes on JAM2-Fc or Fc coated 
areas directly adjacent to the micropillar arrays. We found no significant difference between the densities 
of OPCs or oligodendrocytes between JAM2-Fc and Fc conditions (Fig 4i). Taken together, these results 
show that the extracellular portion of JAM2 is sufficient to specifically inhibit oligodendroglial wrapping 
without affecting cell density or oligodendrocyte differentiation.  
 
JAM2 is necessary to prevent somatodendritic myelin wrapping 
Given that oligodendrocytes wrap nanofibers, beads, and Fc coated micropillars, but significantly fewer 
JAM2-Fc coated micropillars, we next asked whether JAM2 signaling is sufficient to inhibit myelin 
segment formation in vitro. We established myelinating SCN cocultures in the presence of either soluble 
Fc or JAM2-Fc. After seven days, the cocultures were immunostained for MBP and Fc, and the number of 
MBP+ segments per oligodendrocyte was analyzed. Consistent with Fc binding analysis, myelinating 
oligodendrocytes in the control condition do not show specific Fc labeling (Fig 5a), while oligodendrocytes 
in the JAM2-Fc condition show co-labeling of MBP and JAM2-Fc (Fig 5b), indicating that myelinating 
oligodendrocytes express a JAM2 receptor. Interestingly, we find that the number MBP+ segments 
formed per oligodendrocyte is significantly reduced in the presence of JAM2-Fc as compared to Fc alone 
(Fig 5c, 24.6% reduction).  
Next, we investigated whether JAM2 is necessary to prevent somatodendritic myelin wrapping of 
SCNs. First, we established myelinating cocultures with wildtype SCN and OPCs, and allowed them to 
interact normally for five days in vitro. During the final two days of coculture, at the onset of OPC 
differentiation and initiation of myelination, we applied a function-blocking antibody against JAM2 (Fig 
S1a-c). In control conditions, oligodendrocyte segments are overwhelmingly wrapped on axons (Fig S1a). 
However, in the presence of JAM2 function-blocking antibody, we found that oligodendrocytes wrap 
significantly more MBP+ segments on neuronal dendrites (Fig S1b-c, 321.8% increase).  
To understand whether neuronal JAM2 is necessary to ensure that the somatodendritic compartment 
remains unmyelinated, we established myelinating cocultures with wildtype OPCs and either JAM2-
knockout (JAM2 KO) or wildtype (WT) SCNs. We observed that compared to wildtype SCN controls (Fig 
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5d), wildtype oligodendrocytes wrapped significantly more MBP+ segments on JAM2-deficient 
somatodendritic compartments (Fig 5e-f, 226.4% increase). Strikingly, we frequently observed large 
spheroidal ‘bubbles’ of MBP+ membranes in JAM2 KO neuron cocultures (Fig 5e, MBP panel 
arrowheads). These structures stood out against the typically cylindrical myelin segments on axons and 
colocalized with neuronal somata (Fig 5e, MAP2 panel arrowheads). We quantified the relative frequency 
in which neuron cell bodies are wrapped with myelin membranes, and find that JAM2-knockout somata 
are five-fold more likely to be wrapped by oligodendrocytes compared with wildtype controls (Fig 5g).  
During normal axonal myelination, oligodendrocyte adhesion proteins cause the clustering of 
neuronal proteins and ion channels to nodes of Ranvier, enabling saltatory conduction of action potentials. 
We next asked whether aberrant somatic wrapping could affect the molecular organization of JAM2-
knockout neurons? Unexpectedly, we observe that MBP+ membrane wrapping of neuronal somata 
induced the clustering of neuronal contactin-associated protein (CASPR) (Fig S2a, inset 1). Wrapped 
neuronal dendrites also exhibited clustered CASPR (Fig S2a, inset 2), but unwrapped somata and 
dendrites showed no CASPR clusters (Fig S2a, inset 3). This pattern of molecular organization is 
indicative of a direct neuroglial molecular interaction normally restricted to paranodes at the node of 
Ranvier (Einheber et al., 1997; Eisenbach et al., 2009; Pedraza et al., 2009).  
 
Loss of JAM2 results in myelination of the somatodendritic compartment in vivo 
In the more complex environment of the CNS, is inhibitory JAM2 signaling required to prevent myelination 
of the somatodendritic compartment? At postnatal day 30-31 (P30-31) in the mouse, most neurons in the 
cervical spinal cord express JAM2. We examined a JAM2 reporter and JAM2 protein expression in spinal 
cord cross-sections of both jam2:beta-galactosidase knock-in mice (Fig S3a-b), as well as heterozygous 
and JAM2 KO mice, respectively (Fig S3c-d, Fig S4a-b;). The CNS is heavily myelinated and individual 
myelin segments are generally difficult to resolve by immunostaining. One exception to this technical 
limitation is the dorsal horn, where very few axons are myelinated. In this area, we observed many beta-
galactosidase/NeuN-positive neurons (Fig S3a), and robust gray matter JAM2 immunostaining in 
heterozygous but not JAM2 KO mice (Fig S4a-b), confirming the specificity of the antibody staining. In 
P31 littermate wildtype and JAM2 KO mice, we found no significant differences in the average densities 
of NeuN-positive neurons or CC1-positive oligodendrocytes within the dorsal horn region (Fig S3c-f), 
suggesting that the development of these two cell types is normal in the absence of JAM2.  
When we examined myelination patterns in dorsal horns of littermate wildtype and JAM2 KO mice 
(Fig 6a-d), we observed conspicuous MBP+ membrane ‘bubbles’ around neuronal somata in JAM2 KO 
dorsal horns (Fig 6c-d, arrowheads). Seventy-two percent of JAM2 KO hemisections contained more than 
one myelin-wrapped neuron, compared to just 16% of wildtype hemisections (Fig 6e). Overall, the median 
number of wrapped neurons per hemisection was four-fold higher in JAM2 KO mice compared to wildtype 
littermates (Figure 6f). Optical sectioning of immunostained tissue revealed that wrapped neurons could 
be wrapped with MBP-positive membrane around their entire circumference through several micrometers 
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in the z-axis (Fig 6g), reminiscent of myelin-wrapped beads (Fig 1d). One of the hallmarks of myelination 
is the clustering of CASPR to paranodes. Like myelin-wrapped JAM2 KO neurons in vitro (Fig S2a), we 
find that the molecular organization of CASPR on JAM2 KO neurons is dramatically affected by somatic 
myelination in vivo. CASPR protein clustering is evident on MBP+ membrane-wrapped JAM2-knockout 
neurons (Fig S2b). Consistent with our immunostaining observations, semi-thin sections through a JAM2 
KO dorsal horn neuron show myelination around the total circumference of a soma (Fig 6h). This 
particular cell is wrapped across three different semi-thin sections (Fig S2c-e).  
We wanted to further understand the identity of the wrapped Jam2-knockout neurons. Based on 
our observations that Jam2-knockout neurons are generally wrapped around their entire circumference in 
vivo, are small (10-20 micrometer diameter) and have little cytoplasm (Fig 6c,d,g-h; Fig S2b-c), we 
screened dorsal horn interneuron markers, and found that MBP+ wrapped neurons are exclusively 
positive for the paired box gene 2 (PAX2) transcription factor (Figure 7a-e). PAX2+ dorsal horn neurons 
are inhibitory interneurons and their dendrites and axons exhibit islet morphology oriented along the 
rostral-caudal axis of the spinal cord (Smith et al., 2015). We find that approximately six-percent of 
PAX2+ neurons are wrapped in JAM2-knockout mice, significantly more than the under two-percent 
observed in JAM2-heterozygous mice (Fig 7f). We find no difference in the density of PAX2+ neurons in 
the dorsal horn between genotypes (Fig 7g). Finally, we find that PAX2+ neurons receive very little 
presynaptic innervation of their somata (Fig S5a-b) with many cells of both genotypes exhibiting no 
presynaptic puncta (VGLUT1: 64.4%; VGLUT2: 23.3%; VGAT: 30.6%). We also never observed synaptic 
puncta between the wrapping MBP+ sheath and the PAX2+ neuron cell body (Fig S5c, 0/480 PAX2+ 
neurons). Taken together, our observations support the conclusion that oligodendrocyte myelin 
membranes are in direct contact with neural somata as they wrap.  
 
Discussion 
Overall, we show that somatodendritic JAM2 is necessary and sufficient to inhibit oligodendrocyte 
wrapping. Our results support a model of myelin target selection and wrapping in which pre-myelinating 
oligodendrocyte processes (Fig 8a) are normally inhibited by somatodendritic cues, including JAM2 (Fig 
8b). When such inhibitors are missing, as in JAM2 KO mice, oligodendrocytes form aberrant 
somatodendritic myelin wraps (Fig 8c). As growing neurons utilize both attractive and repulsive axon 
guidance cues to precisely target correct brain areas and postsynaptic neurons, our findings indicate that 
oligodendrocytes utilize somatodendritic inhibition, potentially in addition to axonal attraction, to target 
myelin segments specifically to axons (Fig 1a, ‘Inhibition’, ‘Mixed’).  
 
Inhibitory signals guide oligodendrocyte myelination 
The need for inhibitory signaling in tailoring myelination patterns becomes more apparent in neuron-free 
myelination assays. When oligodendroglia are cultured in the presence of permissive nanofibers, 
micropillars and spherical beads, they wrap MBP+ myelin membranes around each structure type, 
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including the 50-micrometer diameter circular base of a micropillar (Figs 1c-d, 4c). These results suggest 
that oligodendroglia have few geometric requirements to form myelin. Indeed, the study of myelination by 
culturing oligodendrocytes on planar glass coverslips has historically been a successful approach 
because the cells readily differentiate and form membrane sheets with myelin-like composition in the 
absence of inductive substrate signaling. Here we use the oligodendrocyte’s flexible wrapping 
requirements to our advantage by adapting the high-throughput micropillar array platform to screen 
integral membrane protein activity on oligodendrocyte wrapping (Fig 4c-i).  Under identical geometric 
conditions, and in the absence of any other molecular cues, oligodendrocytes and OPCs are dramatically 
less likely to wrap micropillars coated with JAM2-Fc (Fig 4e-h), and oligodendrocytes form significantly 
fewer myelin segments in the presence of soluble JAM2-Fc (Fig 5a-c). Interestingly, the magnitude of 
JAM2 inhibition is greater on micropillars (66.6%) than in SCN cocultures (24.6%), opening the possibility 
that axons may express an attractive signal that is able to partially overcome JAM2 inhibition. These 
results demonstrate the sufficiency of JAM2 to inhibit wrapping, and support the model that 
oligodendroglial target selection can be regulated by negative and positive microenvironment cues (Fig 
1a ‘Mixed’). 
Furthermore, JAM2’s inhibition of wrapping is not the result of changes in oligodendroglial cell density 
or differentiation (Figs 4i; S4c-f). In contrast, previously described inhibitors of axonal myelination 
negatively affect oligodendroglial cell adhesion in vitro and/or oligodendrocyte differentiation in vitro and 
in vivo (e.g. LINGO-1, LSAMP) (Lee et al., 2007; Mi et al., 2005; Sharma et al., 2015). It would not 
necessarily be advantageous for an inhibitor of somatodendritic myelination to prohibit oligodendrocyte 
differentiation. Oligodendrocytes would still need to differentiate and myelinate gray matter axons that are 
tightly intermingled with neuron cell bodies and dendrites.    
 
Additional inhibitory myelin guidance molecules 
What additional signal(s) prevent aberrant wrapping of other spinal cord neurons and dendrites? JAM2 is 
widely expressed in the young adult mouse spinal cord (Figs S3, S4a-b). Here we describe the aberrant 
wrapping of dorsal horn neuron cell bodies. Additional EM analysis of heavily myelinated gray matter 
areas may reveal that other neuron somatodendritic compartments are wrapped in JAM2 KO mice that 
are not detectable by immuno- or toluidine blue staining. Nevertheless, it is entirely possible that other 
neuron types may express other inhibitory molecules in addition to, or instead of JAM2. But even among 
JAM2-expressing spinal cord motor neurons, it is notable that their dendrites and cell bodies are densely 
covered with presynaptic terminals (Molofsky et al., 2014), another normally unmyelinated neuronal 
structure. Axon terminals, then, may present either a structural barrier preventing oligodendroglial contact 
with somatodendritic surfaces, or may themselves express a myelination-inhibitory cue that is sufficient to 
prevent oligodendrocyte wrapping with or without somatodendritic expression of JAM2. Unlike ventral 
motor neurons, dorsal horn PAX2+ neurons are largely devoid of presynaptic innervation of their somata 
(Fig S5). Importantly, our data does not distinguish between the possibilities that somatic myelin wrapping 
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removes synapses, or whether only neurons devoid of somatic synaptic terminals are vulnerable to 
myelin wrapping in the absence of JAM2. In addition to neural sources of myelin inhibition, astrocytes, 
microglia, oligodendroglia and endothelial cells also remain unmyelinated, and may each express a 
molecular cue to prevent wrapping.  
 
Oligodendroglial JAM2 receptors 
Many receptors in oligodendroglia may be responsible for transducing myelin guidance signals, especially 
if JAM2 is one of many inhibitory molecules in the CNS. Known JAM2 receptors include other JAM family 
members JAM1, 2 and 3, as well as integrin alpha-4 beta-1, which may act alone or in combination to 
bind JAM2 (Arcangeli et al., 2013). In this study, the identity of the JAM2 receptor(s) in oligodendrocytes 
remains an open question. But if oligodendrocyte differentiation and wrapping are indeed dissociable 
events as our results suggest (Fig 4e-i), the understanding of downstream mechanisms that separately 
govern these two processes will be of high interest for future study. 
 
Inhibitory myelin guidance molecules and failure of myelin repair 
Promoting efficient myelin repair in diseases like multiple sclerosis (MS) has long been a clinical goal. 
While current therapies aim to control immune infiltration into the CNS, more attention is now being given 
to directly promoting oligodendrocyte differentiation and remyelination (Mei et al., 2014; Ruckh et al., 
2012). However, it has also been observed in human postmortem MS lesions that differentiated 
oligodendrocytes are present, but fail to remyelinate axons (Chang et al., 2002). Could inhibitory myelin 
guidance molecules be aberrantly upregulated or mislocalized in MS lesions and prevent efficient repair? 
If so, it is essential to identify such signals, as they may be feasible targets to block and promote myelin 
repair. As additional myelin guidance molecules are identified, it will be important to understand their roles 
in both myelin formation and regeneration.   
 
Experimental Procedures 
Animals 
All animals used in this study were housed and handled with the approval of the University of California 
San Francisco Institutional Animal Care and Use Committee (IACUC). Timed-pregnant Sprague-Dawley 
rats were procured from Jackson Laboratory. Dorsal root ganglion neuron and spinal cord neuron 
dissections were done on embryonic day 15. Junction Adhesion Molecule 2 (JAM2) knockout mice are as 
previously described (Arcangeli et al., 2011). The jam2:beta-galactosidase knock-in mice were purchased 
from Jackson Laboratory (Jam2tm1.1(KOMP)Mbp). Jam2 knockout mice were used to generate data in Figures 
5-6, S3-S4, and Jam2tm1.1(KOMP)Mbp mice were used to generate data in Figures 7, S2 and S5.  
 
Immunohistochemistry 
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Cell cultures were immunostained with standard techniques, discussed elsewhere in detail (Lee et al., 
2013). Briefly, cultures were fixed with 4% paraformaldehyde (Electron Microscopy Tools) in DPBS (Life 
Technologies), washed with PBS, air dried, then blocked and permeabilized in 20% normal goat serum 
(NGS) (Sigma-Aldrich) plus 0.1% Triton X-100 (Sigma-Aldrich) in DPBS. The cultures were incubated in 
20% NGS in dPBS plus primary antibodies. Cultures were washed in PBS, and incubated in 20% NGS in 
dPBS plus secondary antibodies. The cultures were washed in PBS then distilled water, air dried and 
then mounted on microscope slides with Fluorescence Mounting Medium (Dako).   
Spinal cord tissue was collected from P30-33 mice using standard techniques. Briefly, after 
transcardial perfusion with PBS and then 4% paraformaldehyde (Electron Microscopy Tools), the spinal 
cord was dissected out and post-fixed in 4% paraformaldehyde overnight at 4° Celsius and cryoprotected 
by incubation in 30% sucrose in PBS until tissue sank. Coronal sections were cut in 30-micrometer thick 
slices from the cervical spinal cord (C5-C8) using a freezing microtome (Microm HM 450 and KS 34, 
Thermo Scientific). Sections were immunostained with the same methods as cell cultures above. 
Images were collected using a Zeiss Axio Imager Z1 Apotome or M2 Apotome.2 fluorescence 
microscope with either Axiovision or Zen software (Zeiss). Images are shown as a maximum intensity 
projection of optical section z-stacks. Micropillar cultures (Mei et al., 2014) and semi-thin sections were 
imaged using a Zeiss LSM-700 confocal microscope and Zen software.  
 
Antibodies 
Antibodies used for immunostaining are: microtubule associated protein 2 (chicken anti-MAP2, 1:1,000, 
Chemicon AB5543); neurofilament (mouse anti-NF, 1:200, Covance SMI-312R); junction adhesion 
molecule 2 (rabbit anti-JAM2, 1:100-200, ThermoFisher Scientific PA5-21576); myelin basic protein (rat 
anti-MBP, 1:100, Millipore MAB386); p75-neurotrophin receptor (mouse anti-p75NTR, 1:25 hybridoma 
supernatant, MC192); contactin associated protein (mouse anti-CASPR, 1:500, E. Peles laboratory), 
neuronal nuclei (rabbit anti-NeuN, 1:2000 Abcam ab177487), adenomatous polyposis coli (mouse anti-
APC/CC1, 1:200 Millipore OP80), beta-galactosidase (chicken anti-βGal, 1:1000 Aves Labs BGL-1040), 
vesicular glutamate transporter 2 (guinea pig anti-VGLUT2, 1:4,000 Millipore AB2251), vesicular 
glutamate transporter 1 (guinea pig anti-VGLUT1, 1:4,000), vesicular GABA transporter (guinea pig anti-
VGAT, 1:500 Synaptic Systems 131 004), paired box gene 2 (rabbit anti-PAX2, 1:1,000-4,000 Abcam 
ab79389), and platelet derived growth factor receptor-alpha (rabbit anti-PDGFRα, 1:8,000, generous gift 
of W.B. Stallcup, Sanford-Burnham Medical Research Institute, Cancer Center, La Jolla, CA USA). 
Secondary antibodies were Alexa Fluor raised in goat against rat, mouse, rabbit, human or chicken in the 
following wavelengths: 488, 594, 647 (1:1,000 Life Technologies) and nuclei were stained with DAPI. The 
antibodies used in function-blocking experiments (Figure S1): rat anti-JAM2 (5µg/mL, R&D Systems 
MAB9881) or rat IgG (5µg/mL, R&D Systems 6-001-F).  
 
Primary neuron and glia isolation and culture 
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Spinal cord neuron (SCN) isolation and culture has been described previously (Camu and Henderson, 
1992; Molofsky et al., 2014). Briefly, embryonic day 15 rat or mouse embryo spinal cords were dissected 
and meninges removed as much as possible. Spinal cords were chopped with a sterile scalpel blade and 
the tissue was incubated in 0.05% trypsin-EDTA (Life Technologies) for 15 minutes at 37° Celsius. The 
tissue was dissociated into a single-cell suspension and incubated in a series of immunopanning dishes; 
two negative selection dishes coated with monoclonal hybridoma antibodes rat neural antigen-2 (Ran-2, 
ATCC) and Galactocerebrocide (Gal-C (Ranscht et al., 1982)); and one positive selection plate against 
p75 neurotrophin receptor (p75NTR, rat cells: MC192 hybridoma; mouse cells: rabbit anti-p75 function 
blocking antibody ‘REX’, a generous gift of L.F. Reichardt (Weskamp and Reichardt, 1991)). Adherent 
cells were released from the final immunopanning plate with a brief application of 0.05% trypsin-EDTA 
and 200,000-300,000 cells were seeded on 25mm round coverslips prepared with 200µL of 1:25 Matrigel 
(Corning, 356230) in DMEM (Life Technologies). SCN were left to adhere overnight, and flooded with 
growth medium plus 5-fluoro-2’-deoxyuridine (FDU) to kill mitotic cells, and 80% of growth medium was 
changed every three days for 3-4 weeks: DMEM (Life Technologies), B27 (Life Technologies), N2 (Life 
Technologies), penicillin-streptomycin (Life Technologies), N-acetylcisteine (NAC, Sigma-Aldrich), 
forskolin (EMD), insulin (Sigma-Aldrich), brain-derived neurotrophic factor (BDNF, Peprotech), ciliary 
neurotrophic factor (CNTF, Peprotech), glial-derived neurotrophic factor (GDNF, Peprotech).   
 Dorsal root ganglion (DRG) neuron cultures were established as previously described (Mei et al., 
2014). Oligodendrocyte precursor cells (OPCs) were isolated (Lee et al., 2013) and cultured on 
micropillars as previously described (Mei et al., 2014).  
 OPCs were cocultured with 3-4 week old SCN as follows: OPCs were isolated with hybridoma 
anti-A2B5 or anti-O4-coated panning dishes, and 400,000 OPCs were seeded on each SCN culture in 
chemically-defined medium (Lee et al., 2013), which was changed every three days. For Jam2-Fc or Fc 
cocultures (Figure 5), 10 micrograms/mL protein was added to culture medium.  
 
Oligodendrocyte nanofiber and microbead culture 
Aligned polycaprolactone nanofibers were purchased in an 8-chamber slide format (Nanofiber Solutions 
cat 0802). 20 micrometer-diameter NH2 polystyrene beads (Kisker Biotech Gmbh & Co cat PPS-
20.0NH2) were sparsely seeded into the nanofiber chambers, coated with poly-L-lysine and dried to 
promote adhesion of beads to the nanofibers. OPC culture on beads and nanofibers was performed 
essentially as described (Chong et al., 2011; Lee et al., 2013). OPCs were seeded into the chambers and 
cultured for 3-4 days, then fixed and immunostained as above.  
 
Oligodendrocyte coculture on live and cross-linked SCNs 
SCN cultures were established as above. Prior to OPC seeding, SCN cultures were chemically cross-
linked as described (Rosenberg et al., 2008) with 4% paraformaldehyde for 10 minutes at room 
temperature. Fixed neuron cultures were extensively washed in L15 medium + 10% FBS (Gibco), and 
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finally washed with coculture medium. One million OPCs were seeded onto either live or cross-linked 
neurons and cocultured for 5 days (Figure 2) or 7-12 days (Figure 1) in a chemically defined medium, 
then immunostained as above. !
Micropillar protein coating 
Micropillar arrays were sterilized with 100% ethanol and dried. Micropillars were coated with poly-L-lysine 
for one hour at room temperature, washed three times with water and dried. Each micropillar array of 
1000 pillars was then coated with 2µg of either Fc protein (R&D Systems 110-HG) or JAM2-Fc protein 
(R&D Systems 988-VJ-050) in 27µL Tris HCl pH 9.5 overnight at room temperature. The micropillars 
were washed three times with water and twice with oligodendrocyte culture medium and kept wet with 
medium until 40,000 OPCs were seeded.  
 
JAM2-Fc and Fc protein binding assay 
OPCs were seeded onto poly-L-lysine coated coverslips in PDGF-containing culture medium overnight. 
On div 3, coverslips were washed with DMEM and incubated in 2µg/mL JAM2-Fc or Fc in DMEM for 30 
minutes at room temperature. The coverslips were washed three times with DPBS, fixed with 
paraformaldehyde and immunostained as above. 
 
Western Blot Analysis 
Western blotting was performed essentially as previously described (Rosenberg et al., 2008). 25mm 
coverslips containing either SCN alone or myelinating SCN cocultures were collected in 100µL/coverslip 
of ice cold RIPA buffer, kept on ice and frozen immediately at -80°C. Samples were thawed on ice and 
homogenized. Protein concentration was determined by BCA Protein Assay (Thermo Scientific 23225). 
Proteins were transferred to pure nitrocellulose membranes and probed with primary antibodies (see 
Antibodies) and Alexa Fluor 680 secondary antibodies raised in goat (Life Technologies). Imaging was 
conducted with an Odyssey infrared system (LI-COR). 
 
RNA isolation, RNA sequencing and bioinformatics 
Spinal cords and dorsal root ganglia were dissected from a single litter of embryonic-day 15 rat embryos, 
SCN and DRG neurons were isolated and cultured for three weeks as described above. RNA was 
isolated using Trizol Reagent and manufacturer’s protocol (Life Technologies). Sequencing was 
performed with Illumina Genome Analyzer Sequencing System.  Over 142M single end reads of length 
100 bases were sequenced per sample. Sequences were produced with CASAVA (version 1.8.1.) and 
aligned to Rattus norvegicus rn4 genome build using TopHat (version 1.3.0) (Trapnell et al., 2009). 
TopHat was run separately for each RNA-Seq library with the options “--segment-mismatches 1 --min-
intron-length 30 --max-multihits 10 --solexa-quals -o”. Transcriptome was assembled using Cufflinks 
(Roberts et al., 2011; Trapnell et al., 2010) (version 1.1.0) and RefSeq reference annotation file (using the 
options –g).The reference was downloaded from the UCSC tables. The two assembled transcriptomes 
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were merged with the tool Cuffmerge (version 1.1.0.). Cuffdiff was used to detect differentially expressed 
genes and transcripts between the two samples. Identification of the rat transcripts coding for membrane 
and transmembrane proteins was done with Ingenuity® Pathway Analysis (IPA®). The criteria for 
selection of differentially expressed transcripts was a higher expression in SCNs as compared to DRGs 
expression, q values <=0.05 and p values <=0.05.  
 
Quantitative PCR 
Total RNA was extracted from three-week-old spinal cord neuron or dorsal root ganglion neuron cultures 
using Trizol Reagent (Life Technologies), and precipitated using either chloroform and isopropanol or 
PureLink RNA Mini Kit (Life Technologies, cat. 12183020). RNA was reverse transcribed using the 
RETROscript kit oligo-dT primers (Thermo Fisher, cat. AM1710). cDNA was amplified in triplicate using 
Power SYBR Green PCR master mix (Thermo Fisher, cat. 4367659) and primers for either jam2 (Forward 
5’ TACTGTGAAGCCCGCAACTC 3’, Reverse 5’ GCAGAAATGACGAAGGCCAC 3’, product length 122 
base pairs), or gapdh (Forward  5’ GTGCCAGCCTCGTCTCATAG 3’, Reverse 5’ 
AGAGAAGGCAGCCCTGGTAA 3’, product length 91 base pairs). qPCR was run on a 7500 Real Time 
PCR system and analyzed with 7500 software version 2.0.6 (Applied Biosystems). 
 
Electron microscopy 
Transmission electron microscopy of cell cultures is as described previously (Lee et al., 2013; Rosenberg 
et al., 2008). Briefly, cultures were fixed with 4% PFA (Electron Microscopy Tools), incubated in 1% 
osmium tetroxide (Electron Microscopy Tools), then counterstained with 1% uranyl acetate. Samples 
were dehydrated in a series of ethanol dilutions and embedded in 1:1 EMBed-812 resin (Electron 
Microscopy Sciences) to propylene oxide (PPO, Electron Microscopy Sciences), then incubated in a 2:1 
resin to PPO mixture. Cultures were detached from the coverslip with a razor blade and rolled tightly 
before embedding into the final 100% resin block. Ultrathin sections were cut at the W.M. Keck 
Foundation Advanced Microscopy Laboratory and imaged with a JEM1400 Electron Microscope (JEOL) 
in the Zilkha Neurogenetic Institute. Scanning electron microscopy of micropillars is as described 
previously (Mei et al., 2014).  
 
Image analysis and statistics 
The UCSF department of Biostatistics was consulted to identify suitable statistical tests. Statistical 
significance was determined at P-values < 0.05. Statistical tests were applied as described in figure 
legends. Data normality was determined using the Kolmogorov–Smirnov test. N values are indicated in 
the figure legends. 
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Figure Legends 
 
Figure 1. Myelin target selection by oligodendroglia. (a) Models of oligodendrocyte axon selection and 
myelination. Attraction: an attractive cue is expressed on the axon (green), resulting in its myelination by 
the oligodendrocyte, while no myelination cues are present on non-myelinated structures (gray). 
Inhibition: non-myelinated structures express an inhibitory cue (red), resulting in oligodendrocyte process 
inhibition and myelination of inhibition-free axons (gray). Mixed: Inhibitory (red) and attractive (green) 
cues result in the correct myelination of axons. (b) a phase image of a spinal cord neuron (SCN) in 
culture. (c) a phase image of nanofibers and a 20-micrometer diameter polystyrene bead. (d) an 
oligodendrocyte ensheathing myelin basic protein-positive (MBP+, red) membranes on nanofibers and 
the bead shown in (c) with a side-view shown in the inset. (e) a neuron at eight days in vitro 
immunostained for microtubule associated protein 2 (MAP2) and neurofilament (NF). (f) electron 
micrograph of a synapse, and (g) neurofilament-positive axons in SCN cultures. (h) low-magnification 
image of neurons and oligodendroglia in a myelinating coculture. (i) timecourse of oligodendrocyte 
progenitor cell (OPC) and oligodendrocyte protein expression in SCN myelinating cocultures. (j) electron 
micrograph of a myelinated axon in a myelinating spinal cord neuron coculture. Scale bars = 20 
micrometers (d), 10 micrometers (e), 250 nanometers (f), 500 nanometers (g, i), 50 micrometers (h). 
 
Figure 2. Oligodendrocytes wrap somatodendritic compartments of chemically cross-linked 
neurons. (a) an oligodendrocyte (asterisk) forms MBP+ myelin segments on SCN axons (NF, white) but 
not dendrites (MAP2, green). (b) an oligodendrocyte (asterisk) forms myelin segments on 
paraformaldehyde cross-linked SCN axons, dendrites (arrowheads), and somata (arrows). (c) 
quantification of MBP+ ensheathments on either MAP2+ dendrites or NF+ axons in live and cross-linked 
(‘Fixed’) cocultures. (d-e) multiple layers of myelin membrane formed in a cross-linked myelinating 
coculture. DAPI, blue. Bar graph in (c) represents means with s.e.m. error bars. n = 4 experiments 
quantified from 26-30 20x fields per condition per experiment. Significance was calculated using one-
tailed paired Students t-test. P = 0.04. Scale bars = 20 micrometers (a,b), 500 nanometers (d), 100 
nanometers (e). 
 
Figure 3. Differential RNA-Seq and candidate profiling. (a) Experimental procedure for RNA extraction. 
Embryonic day 15 (E15) rat embryos were dissected and their spinal cords and dorsal root ganglia were 
isolated. SCN and dorsal root ganglion neurons (DRG) were separately cultured and their RNA was 
collected for sequencing (RNA-seq). (b) Results of differential RNA-seq. Candidate inhibitory proteins are 
SCN transcripts that are significantly differentially expressed (large pie chart, right), are localized to the 
plasma membrane and have transmembrane domains (pink). Transcripts detected also included other 
SCN transcripts (big pie chart, light gray), SCN enriched, but not significantly differentially expressed 
(small pie chart, gray), DRG-enriched transcripts (black) and not differentially expressed transcripts 
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(n.d.e.). (c) Volcano plot of DRG (black) and SCN (dark gray), SCN candidate (“Candidate”, pink), and not 
significantly differentially expressed (“n.s.”, light gray) transcripts. (d) Examples of differentially expressed 
transcripts from (c). (e) qPCR amplification of jam2 from cultured DRG and SCN, normalized to DRG 
expression. (f) DRG somata and axons (P75, green) immunostained for JAM2 (red), and (g) Cultured 
SCN somatodendritic compartment (MAP2, green) and axons (NF, white), and DAPI, blue. Bar graph in 
(e) represents mean and s.e.m. from n = 4 biological replicates. Gapdh was used as an internal control.  
Scale bars = 20 micrometers. 
 
Figure 4. JAM2 is sufficient to inhibit oligodendrocyte wrapping. (a) JAM2-Fc or (b) Fc protein 
(white) was cultured with MBP+ oligodendrocytes (red) and PDGFRα+ OPCs (green) to demonstrate 
JAM2-Fc binding. (c) scanning electron micrograph micropillar array platform (left column) and 
immunostaining of a cultured oligodendrocyte wrapping a micropillar (MBP, right column) from the x-z 
plane/side view (top row) and x-y plane/top-down view (bottom row). (d) experimental setup: 
oligodendroglia are cultured on coated micropillars (left). Myelin membrane (red) wraps of differentiated 
oligodendrocytes are visualized as rings by taking an optical section (dashed gray box) through 
immunostained cultures (red ring in x-y plane, far right). Optical sections of (e) Fc- and (f) JAM2-Fc-
coated micropillars immunostained for oligodendrocyte (MBP, red) and OPC (PDGFRα, green) wrapping, 
and micropillars (Fc protein, white). (g) The percentage of micropillars with a MBP+ or (h) PDGFRα+ ring, 
and the (i) densities of oligodendoglia on flat areas adjacent to micropillars. Box plots (g,h) are defined by 
the center median line, 25th and 75th percentiles determined by R software, whiskers extend 1.5 times the 
interquartile range from the 25th and 75th percentiles, and dots outside of whiskers are defined as outliers. 
n = 20 fields of 100 micropillars (dots) each condition pooled from four independent experiments. 
Significance was calculated using Wilcoxon Rank-Sum test. (g) *******, P = 6.3x10-8; (h) ***, P = 3.75x10-
4. Bar graphs in (i) represent means with s.e.m. error bars. n = 18 10x fields (dots) each condition pooled 
from three independent experiments. Significance was calculated using two-tailed Students t-test. Scale 
bars: (a-c) 10 micrometers, (e-f) 400 micrometers.  
 
Figure 5. JAM2 is sufficient to reduce myelin segment formation and is necessary to prevent 
somatodendritic wrapping in vitro. Oligodendrocytes in SCN cocultures form myelin segments in the 
presence of soluble (a) Fc or (b) JAM2-Fc protein. (c) the relative number of MBP+ segments formed in 
the presence of Fc or JAM2-Fc. (d) wildtype or (e) JAM2 KO neurons cocultured with wildtype OPCs for 
seven days in vitro.  Arrowheads indicate myelin membranes on neuron soma and asterisks mark 
oligodendrocyte cell bodies. (f) the percentage of myelin membrane structures colocalized with MAP2+ 
and NF- somatodendritic compartments. (g) the percentage of neuron somata wrapped with MBP+ myelin 
membranes. (h) a wildtype MBP+ oligodendrocyte (asterisk) wraps membranes on a JAM2 KO MAP2+ 
neuron in vitro, clustering neuronal CASPR proteins (green).  Bar graphs represent means with s.e.m. 
error bars. (c) n = 4 independent experiments (dots) representing median number of MBP+ segments 
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formed per oligodendrocyte from 59-79 oligodendrocytes quantified per experiment per condition. (f-g) n 
= 9 coverslips (dots) pooled from three independent experiments. Significance was calculated using one-
tailed paired (c) or unpaired (f-g) Students t-test. (c) *, P = 0.032; (f) ****, P = 7.1x10-5; (g) **, P = 0.0012. 
DAPI, blue. Scale bars: 20 micrometers. 
 
Figure 6. JAM2 is necessary to inhibit somatic wrapping in vivo. (a) dorsal horn (dotted yellow line) 
in a coronal section of a wildtype spinal cord immunostained for MBP. (b) higher magnification of dorsal 
horn myelin (top, red), neurons (middle, green), and merged (bottom). (c-d) same as (a-b) but in JAM2 
KO mice. Arrowheads indicate MBP+ wrapped MAP2+ neurons. (e) number of myelin wrapped dorsal 
horn neurons per hemisection (one dot = one hemisection, colors indicate littermate pairs). (f) bar graph 
of median number of wrapped neurons per hemisection per mouse. Connected diamonds indicate 
littermate pairs, and fill color corresponds to dots in (e). n = 5 littermate pairs, median taken from ten 
hemisections per mouse. *, P = 0.034; Wilcoxon Paired Signed-Ranks test. (g) a myelin wrapped neuron 
from a JAM2 KO dorsal horn imaged through an 11 micrometer thick z-stack. Individual columns labeled 
by z-plane depth, and a maximum intensity projection is shown in the far-right column. (h) a toluidine blue 
stained semi-thin section from a JAM2 KO mouse dorsal horn shows a myelin-wrapped neuron (pseudo-
colored green cytoplasm and blue nucleus). Scale bars: (a-d) 50 micrometers, (g-h) 10 micrometers. 
DAPI, blue.  
 
Figure 7. Pax2+ neurons are wrapped in JAM2 knockout mice. (a) dorsal horn immunostained for 
MBP, (b) Pax2, (c) label a subset of wrapped (d) MAP2+ neurons. (e) quantification of the percent of 
MBP+ ‘bubbles’ on Pax2+ neurons. (f) quantification of the percent of Pax2+ neurons wrapped by MBP+ 
‘bubbles’. (g) number of Pax2+ neurons per square millimeter in Jam2 +/- and Jam2-/- littermate pairs. n 
= 4 littermate pairs. Bar graphs represent: (e-f) median calculated as (e) total wrapped Pax2+ out of total 
wrapped cells per mouse, or (f) percent per field from 10 20x fields per mouse. Error bars represent 
median absolute deviation; (g) mean density per mouse calculated from 10 20x fields per mouse. Error 
bars represent s.e.m. *, P = 0.034; Wilcoxon Paired Signed-Ranks test. Scale bar: 50 micrometers. 
 
Figure 8. Model of JAM2 function on oligodendrocyte wrapping. (a) a pre-myelinating process of an 
oligodendrocyte comes into contact with the somatodendritic compartment of a neuron. (b) in wildtype 
mice, somatodendritic JAM2 inhibits the oligodendrocyte process from wrapping. (c) when JAM2 is 
absent or blocked, the oligodendrocyte process is not inhibited, and continues to wrap myelin membranes 
on the neuron cell body. 
 
Supplemental Figure 1. JAM2 function is necessary to prevent dendritic wrapping in vitro. (a) 7div 
myelinating SCN cultures incubated for the final two days with either IgG or (b) anti-JAM2 function 
blocking antibody. Oligodendrocytes (asterisks) wrap myelin membranes on axons (arrowheads) and on 
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dendrites (arrows). (c) the percentage of MBP+ myelin segments on MAP2+/NF- dendrites. Bar graphs 
represent means with s.e.m. error bars. Significance was calculated using one-tailed Students t-test. **, P 
= 0.0072. Scale bar: 10 micrometers. 
 
Supplemental Figure 2. Oligodendrocyte ensheathment of JAM2 KO neurons in vitro and in vivo 
clusters somatodendritic CASPR protein. (a) a myelinating SCN coculture immunostained for MBP 
(red), CASPR (green) and MAP2 (white). Insets demonstrate examples of (a1) clustered CASPR on a 
wrapped neuron cell body, (a2) clustered CASPR on a wrapped dendrite, and (a3) no clustered CASPR 
signal on an unwrapped MAP2+ neuron.  (b) a MAP2+ JAM2 KO dorsal horn neuron is wrapped in vivo 
by an MBP+ oligodendrocyte. At the edges of the MBP+ membrane is a spiraling line of clustered CASPR 
protein on the neuron surface. (c-e) a myelin-wrapped dorsal horn JAM2 KO neuron in three adjacent 
semi-thin sections stained with toluidine blue. The neuron cytoplasm is pseudo-colored green, and its 
nucleus is pseudo-colored blue. DAPI, blue. Scale bars: (a-c) 10 micrometers. 
 
 
Supplemental Figure 3. JAM2 is widely expressed in spinal cord gray matter. Low-field images of 
the (a) dorsal and (b) ventral horns in a heterozygous jam2:beta-galactosidase knock-in reporter mouse 
shows widespread colocalization of NeuN+ beta-galactosidase+ cells. The ventral horns of (c) jam2 
heterozygous and (d) knockout mice show the presence of JAM2 protein on large neurons in MAP2+ gray 
matter. DAPI, blue. Scale bars: 50 micrometers. 
 
Supplemental Figure 4. The spinal cord dorsal horn develops normally in JAM2 KO mice. Cross-
sections of (a) JAM2 heterozygous (JAM2 Het) and (b) JAM2 KO show specific antibody labeling of JAM2 
(white) on MAP2+ neuron cell bodies (arrowheads) in dorsal horn gray matter. In the dorsal horns of (c) 
WT and (d) JAM2 KO mice the densities of NeuN+ neurons and CC1+ oligodendrocytes is not 
significantly different. Quantification of  (e) NeuN+ and (f) CC1+ cells in WT and JAM2 KO mouse dorsal 
horns. Bar graphs represent means with s.e.m. error bars. n = 3 littermate pairs. Significance was 
calculated using the paired two-tailed Students t-test. DAPI, blue. Scale bars: 20 micrometers. 
 
 
Supplemental Figure 5. Pax2+ dorsal horn neurons have no or few somatic synapses in vivo. 
Quantification of the number of (a) VGLUT1, VGLUT2 or VGAT synapses onto PAX2+ neuronal somata 
in Jam2 -/- or Jam2 +/- mice. (b) VGAT puncta on a Pax2+ neuron soma. (c) a Pax2+ neuron wrapped by 
MBP+ membrane has no VGLUT1+ synaptic puncta on its soma. Bar graphs represent mean with s.e.m. 
error bars. n = 4 littermate pairs. Significance was calculated using the two-tailed Mann-Whitney U test. 
Scale bars: (b-c) 10 micrometers. 
 













